The European Uro-Oncology Group Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2015
NCT02814968
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

The European Uro-Oncology Group (EUOG)